Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05484> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05484 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05484 label "MDX-018 [drugbank:DB05484]" assertion.
- drugbank:DB05484 seeAlso DB05484 assertion.
- drugbank:DB05484 description "MDX-018, also known as HuMax-Inflam, is a fully human antibody that is directed to IL-8 (interleukin-8) and may have potential application in oncology and inflammation. Trials will initially focus on studies to treat glioblastoma, a cancer of the central nervous system. Other possible indications include chronic obstructive pulmonary disease (COPD) and pustular dermatoses. In pre-clinical studies, HuMax-Inflam has been shown to inhibit tumor growth in tumor models using primary human tumors in immunodeficient mice. HuMax-Inflam was also effective in reducing disease activity in palmoplantar pustulosis patients in a clinical study." assertion.
- drugbank:DB05484 identifier "drugbank:DB05484" assertion.
- drugbank:DB05484 title "MDX-018" assertion.
- drugbank:DB05484 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05484 drugbank_vocabulary:drugbank-id "DB05484" assertion.
- drugbank:DB05484 bio2rdf_vocabulary:x-identifiers.org DB05484 assertion.
- drugbank:DB05484 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05484" assertion.
- drugbank:DB05484 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05484 bio2rdf_vocabulary:identifier "DB05484" assertion.